Thorne Healthtech, Inc. Common Stock
THRN
THRN was delisted on the 13th of October, 2023.
49 hedge funds and large institutions have $26.7M invested in Thorne Healthtech, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 7 closing their positions.
144% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 9
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
2% more funds holding
Funds holding: 48 → 49 (+1)
14% less capital invested
Capital invested by funds: $31.1M → $26.7M (-$4.41M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.87M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$508K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$370K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$329K |
| 5 |
Millennium Management
New York
|
+$294K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$708K |
| 2 |
Renaissance Technologies
New York
|
-$513K |
| 3 |
MA
MYDA Advisors
Woodmere,
New York
|
-$340K |
| 4 |
LCM
Laurion Capital Management
New York
|
-$182K |
| 5 |
Norges Bank
Oslo,
Norway
|
-$165K |
THRN Hedge Fund Activity: Q2 2022 in Review
49 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Thorne Healthtech, Inc. Common Stock (THRN) for Q2 2022, worth a combined $26.7M — down 14% from $31.1M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new THRN positions and 7 closed out — a net gain of 3 holders — while 22 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock, adding an estimated $1.87M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $708K sold.
- 49 institutional investors held Thorne Healthtech, Inc. Common Stock (THRN) as of Q2 2022, up from 48 in Q1 2022.
- Funds reported $26.7M of Thorne Healthtech, Inc. Common Stock stock for Q2 2022, down 14% quarter-over-quarter.
- 10 funds opened new Thorne Healthtech, Inc. Common Stock positions in Q2 2022 and 7 closed out, a net change of +3 holders.
- The largest Thorne Healthtech, Inc. Common Stock buyer in Q2 2022 was BlackRock, an estimated $1.87M added.
- The largest Thorne Healthtech, Inc. Common Stock seller in Q2 2022 was Monashee Investment Management, an estimated $708K sold.
Based on aggregated 13F filings for Q2 2022.